PT94514A - Processo para a producao de factor inibidor da sintese de citocinas, de seus antagonistas e metodos para a utilizacao dos mesmos - Google Patents

Processo para a producao de factor inibidor da sintese de citocinas, de seus antagonistas e metodos para a utilizacao dos mesmos

Info

Publication number
PT94514A
PT94514A PT94514A PT9451490A PT94514A PT 94514 A PT94514 A PT 94514A PT 94514 A PT94514 A PT 94514A PT 9451490 A PT9451490 A PT 9451490A PT 94514 A PT94514 A PT 94514A
Authority
PT
Portugal
Prior art keywords
synthesis
antagonists
production
cytocines
methods
Prior art date
Application number
PT94514A
Other languages
English (en)
Other versions
PT94514B (pt
Inventor
Timothy R Mosmann
Kevin W Bond
Marthan W Bond
Paulo J M Vieira
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of PT94514A publication Critical patent/PT94514A/pt
Publication of PT94514B publication Critical patent/PT94514B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5428—IL-10
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT94514A 1989-06-28 1990-06-27 Processo para a producao de factor inibidor da sintese de citocinas, de seus antagonistas e metodos para a utilizacao dos mesmos PT94514B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37266789A 1989-06-28 1989-06-28
US45395189A 1989-12-20 1989-12-20

Publications (2)

Publication Number Publication Date
PT94514A true PT94514A (pt) 1991-04-18
PT94514B PT94514B (pt) 1998-02-27

Family

ID=27005854

Family Applications (1)

Application Number Title Priority Date Filing Date
PT94514A PT94514B (pt) 1989-06-28 1990-06-27 Processo para a producao de factor inibidor da sintese de citocinas, de seus antagonistas e metodos para a utilizacao dos mesmos

Country Status (22)

Country Link
EP (2) EP0567450B1 (pt)
JP (1) JP2813063B2 (pt)
KR (1) KR0183035B1 (pt)
CN (3) CN1051393A (pt)
AT (1) ATE180833T1 (pt)
AU (1) AU635058B2 (pt)
CA (1) CA2062763C (pt)
CS (1) CS414591A3 (pt)
DE (1) DE69033143T2 (pt)
DK (1) DK0567450T3 (pt)
ES (1) ES2132068T3 (pt)
FI (1) FI107926B (pt)
GR (1) GR3030404T3 (pt)
HK (3) HK1008834A1 (pt)
HU (1) HU216310B (pt)
IL (1) IL94878A (pt)
NO (1) NO301718B1 (pt)
NZ (1) NZ234291A (pt)
PT (1) PT94514B (pt)
SG (1) SG52282A1 (pt)
TW (1) TW218383B (pt)
WO (1) WO1991000349A1 (pt)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5827513A (en) * 1990-06-29 1998-10-27 Schering Corporation Methods of treating insulin-dependent diabetes mellitus by administration of IL-10
ATE116550T1 (de) * 1991-01-16 1995-01-15 Schering Corp Behandlung von neoplastischen krankenheiten mit interleukin-10.
US6106823A (en) 1991-01-16 2000-08-22 Schering Corporation Treatment of neoplastic disease with interleukin-10
DE69203443T2 (de) * 1991-01-16 1995-12-07 Schering Corp Verwendung von interleukin-10 in der adoptive immunotherapie von krebs.
DE4122402A1 (de) * 1991-07-04 1993-01-07 Schering Ag Verwendung von interleukin 10 zur herstellung von arzneimitteln mit tumorhemmender wirksamkeit
US5833976A (en) * 1991-08-06 1998-11-10 Schering Corporation Use of interleukin-10 (IL-10) to treat endotoxin- or superantigen-induced toxicity
HU224437B1 (hu) * 1991-08-06 2005-09-28 Schering Corp. Eljárás interleukin-10 analógokat vagy antagonistákat tartalmazó endotoxin- vagy szuperantigén-indukált toxicitás kezelésére szolgáló gyógyszerkészítmények előállítására
ZA931489B (en) * 1992-03-04 1993-10-28 Schering Corp Use of interleuken-10 to suppress graft-vs-host disease
US6277635B1 (en) 1992-03-04 2001-08-21 Schering Corporation Use of interleukin-10 to produce a population of suppressor cells
US6884410B1 (en) 1992-03-04 2005-04-26 Schering Corporation Methods for modulating antigen-specific immune responses
WO1993018783A1 (en) * 1992-03-20 1993-09-30 Schering Corporation Use of interleukin-10 to induce the production of interleukin-1 receptor antagonist
JP3494647B2 (ja) * 1992-08-20 2004-02-09 シェリング・コーポレーション Ｉｌ−４および／またはｉｌ−１０ならびにそれらに対する抗体の新規な用途
US5601815A (en) * 1992-08-21 1997-02-11 Schering Corp IL-4 and IL-10 to downregulate delayed-type hypersensitivity and cytokine expresion by T-cells
CA2144648A1 (en) * 1992-09-18 1994-03-31 Mario Clerici Restoration of immunocompetency to t helper cells in hiv infected patients
CA2145863A1 (en) * 1992-10-01 1994-04-28 Martha W. Bond Use of il-10 to prevent or treat insulin-dependent diabetes mellitus
TW381026B (en) * 1993-01-13 2000-02-01 Schering Corp Method of extracorporally activating cytolytic activity of peripheral blood mononuclear cells and pharmaceutical composition comprising the activated peripheral blood mononuclear cells
CA2155109A1 (en) * 1993-02-01 1994-08-18 Daniel Abramowicz Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10
US5328989A (en) * 1993-03-05 1994-07-12 Schering-Plough Purification of human interleukin-10 from a cell culture medium
US5449688A (en) * 1993-03-30 1995-09-12 The United States Of America As Represented By The Department Of Health And Human Services Method of treating chronic inflammatory diseases
SK150596A3 (en) * 1993-07-26 1997-04-09 Schering Corp Agonists and antagonists of human interleukin-10
US5650060A (en) * 1994-01-28 1997-07-22 Minnesota Mining And Manufacturing Company Ionically conductive agent, system for cathodic protection of galvanically active metals, and method and apparatus for using same
BR9508243A (pt) * 1994-07-05 1997-10-21 Steeno Res Group As Imunomoduladores
US5770190A (en) * 1995-07-14 1998-06-23 Schering Corporation Method of treatment of acute leukemia with inteleukin-10
CN101307106B (zh) * 1995-12-13 2013-06-12 儿童医学中心公司 内皮细胞增殖抑制剂及其应用方法
AU4385696A (en) * 1996-01-18 1997-08-11 Christian Gronhoj Larsen Synthetic il-10 analogues
CN1216470A (zh) * 1996-04-17 1999-05-12 帕特里克·T·普伦德加斯特 脱氢表雄酮组合治疗方法
WO1998009644A2 (en) * 1996-09-06 1998-03-12 Schering Corporation Method for lowering cholesterol levels
AU5221998A (en) * 1997-04-17 1998-11-13 Patrick T. Prendergast Combination therapy utilising 17-ketosteroids and interleukin inhibitors, or interleukin-10 potionally with interleukin inhibitors
US6465176B1 (en) * 1998-10-02 2002-10-15 Message Pharmaceuticals, Inc. Method for identifying compounds RNA/RNA binding protein interactions
AU5047600A (en) * 1999-05-27 2000-12-18 Schering Corporation Mammalian interleukin-10 homologs: il-d110 and il-d210
BR0109705A (pt) 2000-03-31 2005-01-11 Idec Pharma Corp Uso combinado de anticorpos ou antagonistas anti-citocina e anticd20 para o tratamento de linfoma de célula b
WO2011159881A2 (en) 2010-06-16 2011-12-22 Allergan, Inc. Il-10 and methods of treating ocular and other diseases
WO2017160599A1 (en) 2016-03-14 2017-09-21 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Use of cd300b antagonists to treat sepsis and septic shock
WO2018106959A1 (en) 2016-12-07 2018-06-14 Progenity Inc. Gastrointestinal tract detection methods, devices and systems
EP3600414A1 (en) 2017-03-30 2020-02-05 Progenity Inc. Treatment of a disease of the gastrointestinal tract with il-10 or an il-10 agonist
KR20210095165A (ko) 2018-11-19 2021-07-30 프로제너티, 인크. 바이오의약품으로 질환을 치료하기 위한 방법 및 디바이스
EP4309722A2 (en) 2019-12-13 2024-01-24 Biora Therapeutics, Inc. Ingestible device for delivery of therapeutic agent to the gastrointestinal tract
GB202003428D0 (en) * 2020-03-10 2020-04-22 Univ Dundee IL-10 mutiens

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL78197A (en) * 1985-03-22 1991-07-18 Genentech Inc Nucleic acid encoding tgf-beta and its uses
IE62650B1 (en) * 1989-08-04 1995-02-22 David & Sons Ltd Dispensing apparatus
PT96231B (pt) * 1989-12-20 1998-09-30 Schering Corp Metodo para a producao de proteinas bcrf1 uteis com inibidores do interferao gama e metodo para a sua utilizacao

Also Published As

Publication number Publication date
EP0567450A1 (en) 1993-11-03
JPH04502560A (ja) 1992-05-14
ATE180833T1 (de) 1999-06-15
NO915115D0 (no) 1991-12-27
IL94878A (en) 2003-01-12
SG52282A1 (en) 1998-09-28
HK1040531B (zh) 2008-01-11
PT94514B (pt) 1998-02-27
NO301718B1 (no) 1997-12-01
DK0567450T3 (da) 1999-12-13
FI916126A0 (fi) 1991-12-27
DE69033143T2 (de) 1999-10-21
HUT61048A (en) 1992-11-30
CN1317569A (zh) 2001-10-17
KR920701437A (ko) 1992-08-11
FI107926B (fi) 2001-10-31
HU216310B (hu) 1999-06-28
HU906705D0 (en) 1992-03-30
JP2813063B2 (ja) 1998-10-22
DE69033143D1 (de) 1999-07-08
EP0405980A1 (en) 1991-01-02
CN1318589C (zh) 2007-05-30
GR3030404T3 (en) 1999-09-30
NZ234291A (en) 1992-11-25
CN1051393A (zh) 1991-05-15
IL94878A0 (en) 1991-04-15
TW218383B (pt) 1994-01-01
AU635058B2 (en) 1993-03-11
HK1008834A1 (en) 1999-05-21
CA2062763A1 (en) 1990-12-29
CA2062763C (en) 2010-01-05
NO915115L (no) 1992-02-26
AU6077090A (en) 1991-01-17
HK1040493A1 (en) 2002-06-14
HK1040531A1 (en) 2002-06-14
CN1198642C (zh) 2005-04-27
EP0567450B1 (en) 1999-06-02
CN1317343A (zh) 2001-10-17
KR0183035B1 (ko) 1999-04-01
ES2132068T3 (es) 1999-08-16
HK1040493B (zh) 2005-12-16
WO1991000349A1 (en) 1991-01-10
CS414591A3 (en) 1992-12-16

Similar Documents

Publication Publication Date Title
PT94514A (pt) Processo para a producao de factor inibidor da sintese de citocinas, de seus antagonistas e metodos para a utilizacao dos mesmos
DK0504177T3 (da) IL-11, et pattedyrcytokin
IT8721005A0 (it) Metodo per la preservazione difogli trapiantabili di epitelio coltivato in vitro vitale.
PT94326A (pt) Processo para a preparacao de polipeptidios e seus analogos e de composicoes farmaceuticas que os contem
IT8920917A0 (it) Processo per la preparazione di peraloeteri da peraloolefine e nuovi peraloeteri ottenuti.
BR8803675A (pt) Triazinas substituidas,processo para sua preparacao,composicoes herbicidas,aplicacao e processo para preparacao de composicoes
ES2014448B3 (es) Composiciones protectoras para madera y proceso para su produccion.
IT8621857A0 (it) Cinnamilammine, processo per laloro preparazione e composizioni farmaceutiche che le contengono.
IT8820699A0 (it) Centro di montaggio di mobili esimili.
BR8805703A (pt) Vidro para aplicacoes oftalmicas
BR9405994A (pt) Processo para tratar pássaros imaturos com il-2
KR900016551U (ko) 진열장의 냉각장치
IT8919120A0 (it) Procedimento rapido per il temperaggio di cioccolato.
ITMI931034A1 (it) Processo per la preparazione di proteine inibenti i ribosomi
ES2062317T3 (es) Procedimiento e intermedios para la preparacion de 3s-amino-2r-hidroxi-alcanoatos de isopropilo.
BR8604013A (pt) Processo para preparacao de composto n-(2,6-difluorobenzoil)-n'-3,5-dicloro-4-3,3,3-trifluoro-2-cloro prop-1-en-1-il fenil-ureia
IT212632Z2 (it) Contenitore-classificatore per oggetti piatti,in particolare per dischi di computer
TH5761B (th) วิธีการเตรียมชิ้นกล้าสำหรับการเลี้ยงเนื้อเยื่อพืช
IT8945801A0 (it) Procedimento per la fabbricazione di pannelli sagomati per mobili
LT2571B (lt) Imunofermentinis metodas antikunams pries galviju leukozes virusa nustatyti
GR1000396B (el) Νεο ολιγομερες παραγωγον πολυαιθοξυλιωμενης λιπαρας αμινης-η μεθοδος παραγωγης αυτου-η εφαρμογη του δια την τροποποιησιν των επιφανειακων ιδιοτητων των πολυμερων.
ES1001872Y (es) Mueble para equipos de alta fidelidad y similares
BR6702652U (pt) Mesa regulavel para retroprojetores
IT209834Z2 (it) Fermavetro per antine di mobili e simili.
IT1221997B (it) 4 april 1,4 diidropiridin 3,5 dicarbossilati,processo per la loro preparazione e composizioni farmaceutiche che li contengono

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19971128

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20121128